Adaptive Biotechnologies (ADPT) Net Cash Flow Growth (3y) (2021 - 2026)
Powered by 
Analysis
Adaptive Biotechnologies (ADPT) Net Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | 29.31% |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 89.23% |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | -35.93% |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | 11.05% |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | - |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | - |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 28.25% |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | 82.30% |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | -9.56% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 82.30% |
| Mar 31, 2026 | 16.46% |
| Dec 31, 2025 | 28.49% |
| Sep 30, 2025 | -56.22% |
| Jun 30, 2025 | 42.01% |
| Mar 31, 2025 | 28.17% |
| Dec 31, 2024 | -16.35% |
| Sep 30, 2024 | 29.40% |
| Jun 30, 2024 | -45.48% |
| Mar 31, 2024 | -50.20% |
| Dec 31, 2023 | 60.15% |
| Sep 30, 2023 | -29.19% |
| Jun 30, 2023 | -53.62% |
| Mar 31, 2023 | -66.16% |
| Dec 31, 2022 | -99.13% |
| Sep 30, 2022 | 70.33% |
| Jun 30, 2022 | 15.19% |
| Mar 31, 2022 | -34.39% |
| Dec 31, 2021 | -9.52% |
| Sep 30, 2021 | -111.87% |